Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors

Maki Tanioka, Hiroshi Nokihara, Noboru Yamamoto, Yasuhide Yamada, Kazuhiko Yamada, Yasushi Goto, Toshio Fujimoto, R. Sekiguchi, Kazunori Uenaka, Sophie Callies,

Cancer Chemotherapy and Pharmacology · 2010 · 83 citations · 16 references

Concepts

References

16